Come up with a name for your new list and we'll add to it:
Icon Bioscience was acquired by
EyePoint Pharmaceuticals on March 28, 2018.
Icon Bioscience (IBI) is a privately held company focused on the development and commercialization of novel ophthalmic pharmaceuticals, based on its proprietary drug delivery platform, Verisome. IBI's…